CompoAtlas

gemmothérapie de poirier

Food supplement declared in France, decision dated 13 March 2026

gemmothérapie de poirier (Clo.rofil) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pyrus communis 0.54 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Clo.rofil
Food business operator placing the product on the market
Clo.rofil
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
15 gouttes maximum sans un fond d'eau
Directions for use
1 prise pas jour. Augmenter progressivement si necessairre jusqu'a 15 gouttes. cure de 3 semaines minimum est recommander. renouveler 3X avec une semaine d arrêt entre les cures.
Intended populations
Men and women aged 18 and over, Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Pregnant women, Taking medication
Objectives stated by the manufacturer (these are not authorised claims)
Bones, Digestion, Joints

Declaration 358874, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Pyrus communis L.BourgeonAlcoolature0.54 mg

Other ingredients

eau, sirop d'agave, Alcool éthylique

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes ou allaitantes et aux personnes de moins de 18 ans. En cas de traitement médicamenteux, demander l’avis d’un professionnel de santé. Ne pas dépasser la dose journalière recommandée. Ne se substitue pas à une alimentation variée et équilibrée et à un mode de vie sain. Tenir hors de portée des jeunes enfants.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Clo.rofil

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “gemmothérapie de poirier (Clo.rofil): composition and regulation”, https://compoatlas.com/en/supplements/products/358874-gemmotherapie-de-poirier, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line